Global Regorafenib Market Growth 2022-2028

1.1 Market Introduction

1.2 Years Considered

1.3 Research Objectives

1.4 Market Research Methodology

1.5 Research Process and Data Source

1.6 Economic Indicators

1.7 Currency Considered

2 Executive Summary

2.1 World Market Overview

2.1.1 Global Regorafenib Annual Sales 2017-2028

2.1.2 World Current & Future Analysis for Regorafenib by Geographic Region, 2017, 2022 & 2028

2.1.3 World Current & Future Analysis for Regorafenib by Country/Region, 2017, 2022 & 2028

2.2 Regorafenib Segment by Type

2.2.1 Bottled Packaging

2.2.2 Film Coated Packaging

2.3 Regorafenib Sales by Type

2.3.1 Global Regorafenib Sales Market Share by Type (2017-2022)

2.3.2 Global Regorafenib Revenue and Market Share by Type (2017-2022)

2.3.3 Global Regorafenib Sale Price by Type (2017-2022)

2.4 Regorafenib Segment by Application

2.4.1 Metastatic Colorectal Cancer

2.4.2 Advanced Gastrointestinal Stromal Tumours

2.4.3 Advanced Hepatocellular Carcinoma

2.4.4 Other

2.5 Regorafenib Sales by Application

2.5.1 Global Regorafenib Sale Market Share by Application (2017-2022)

2.5.2 Global Regorafenib Revenue and Market Share by Application (2017-2022)

2.5.3 Global Regorafenib Sale Price by Application (2017-2022)

3 Global Regorafenib by Company

3.1 Global Regorafenib Breakdown Data by Company

3.1.1 Global Regorafenib Annual Sales by Company (2020-2022)

3.1.2 Global Regorafenib Sales Market Share by Company (2020-2022)

3.2 Global Regorafenib Annual Revenue by Company (2020-2022)

3.2.1 Global Regorafenib Revenue by Company (2020-2022)

3.2.2 Global Regorafenib Revenue Market Share by Company (2020-2022)

3.3 Global Regorafenib Sale Price by Company

3.4 Key Manufacturers Regorafenib Producing Area Distribution, Sales Area, Product Type

3.4.1 Key Manufacturers Regorafenib Product Location Distribution

3.4.2 Players Regorafenib Products Offered

3.5 Market Concentration Rate Analysis

3.5.1 Competition Landscape Analysis

3.5.2 Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

3.6 New Products and Potential Entrants

3.7 Mergers & Acquisitions, Expansion

4 World Historic Review for Regorafenib by Geographic Region

4.1 World Historic Regorafenib Market Size by Geographic Region (2017-2022)

4.1.1 Global Regorafenib Annual Sales by Geographic Region (2017-2022)

4.1.2 Global Regorafenib Annual Revenue by Geographic Region

4.2 World Historic Regorafenib Market Size by Country/Region (2017-2022)

4.2.1 Global Regorafenib Annual Sales by Country/Region (2017-2022)

4.2.2 Global Regorafenib Annual Revenue by Country/Region

4.3 Americas Regorafenib Sales Growth

4.4 APAC Regorafenib Sales Growth

4.5 Europe Regorafenib Sales Growth

4.6 Middle East & Africa Regorafenib Sales Growth

5 Americas

5.1 Americas Regorafenib Sales by Country

5.1.1 Americas Regorafenib Sales by Country (2017-2022)

5.1.2 Americas Regorafenib Revenue by Country (2017-2022)

5.2 Americas Regorafenib Sales by Type

5.3 Americas Regorafenib Sales by Application

5.4 United States

5.5 Canada

5.6 Mexico

5.7 Brazil

6 APAC

6.1 APAC Regorafenib Sales by Region

6.1.1 APAC Regorafenib Sales by Region (2017-2022)

6.1.2 APAC Regorafenib Revenue by Region (2017-2022)

6.2 APAC Regorafenib Sales by Type

6.3 APAC Regorafenib Sales by Application

6.4 China

6.5 Japan

6.6 South Korea

6.7 Southeast Asia

6.8 India

6.9 Australia

6.10 China Taiwan

7 Europe

7.1 Europe Regorafenib by Country

7.1.1 Europe Regorafenib Sales by Country (2017-2022)

7.1.2 Europe Regorafenib Revenue by Country (2017-2022)

7.2 Europe Regorafenib Sales by Type

7.3 Europe Regorafenib Sales by Application

7.4 Germany

7.5 France

7.6 UK

7.7 Italy

7.8 Russia

8 Middle East & Africa

8.1 Middle East & Africa Regorafenib by Country

8.1.1 Middle East & Africa Regorafenib Sales by Country (2017-2022)

8.1.2 Middle East & Africa Regorafenib Revenue by Country (2017-2022)

8.2 Middle East & Africa Regorafenib Sales by Type

8.3 Middle East & Africa Regorafenib Sales by Application

8.4 Egypt

8.5 South Africa

8.6 Israel

8.7 Turkey

8.8 GCC Countries

9 Market Drivers, Challenges and Trends

9.1 Market Drivers & Growth Opportunities

9.2 Market Challenges & Risks

9.3 Industry Trends

10 Manufacturing Cost Structure Analysis

10.1 Raw Material and Suppliers

10.2 Manufacturing Cost Structure Analysis of Regorafenib

10.3 Manufacturing Process Analysis of Regorafenib

10.4 Industry Chain Structure of Regorafenib

11 Marketing, Distributors and Customer

11.1 Sales Channel

11.1.1 Direct Channels

11.1.2 Indirect Channels

11.2 Regorafenib Distributors

11.3 Regorafenib Customer

12 World Forecast Review for Regorafenib by Geographic Region

12.1 Global Regorafenib Market Size Forecast by Region

12.1.1 Global Regorafenib Forecast by Region (2023-2028)

12.1.2 Global Regorafenib Annual Revenue Forecast by Region (2023-2028)

12.2 Americas Forecast by Country

12.3 APAC Forecast by Region

12.4 Europe Forecast by Country

12.5 Middle East & Africa Forecast by Country

12.6 Global Regorafenib Forecast by Type

12.7 Global Regorafenib Forecast by Application

13 Key Players Analysis

13.1 Bayer Pharmaceuticals

13.1.1 Bayer Pharmaceuticals Company Information

13.1.2 Bayer Pharmaceuticals Regorafenib Product Offered

13.1.3 Bayer Pharmaceuticals Regorafenib Sales, Revenue, Price and Gross Margin (2020-2022)

13.1.4 Bayer Pharmaceuticals Main Business Overview

13.1.5 Bayer Pharmaceuticals Latest Developments

13.2 Beacon Pharmaceuticals

13.2.1 Beacon Pharmaceuticals Company Information

13.2.2 Beacon Pharmaceuticals Regorafenib Product Offered

13.2.3 Beacon Pharmaceuticals Regorafenib Sales, Revenue, Price and Gross Margin (2020-2022)

13.2.4 Beacon Pharmaceuticals Main Business Overview

13.2.5 Beacon Pharmaceuticals Latest Developments

13.3 Drug International

13.3.1 Drug International Company Information

13.3.2 Drug International Regorafenib Product Offered

13.3.3 Drug International Regorafenib Sales, Revenue, Price and Gross Margin (2020-2022)

13.3.4 Drug International Main Business Overview

13.3.5 Drug International Latest Developments

14 Research Findings and Conclusion

Table 1. Regorafenib Annual Sales CAGR by Geographic Region (2017, 2022 & 2028) & ($ millions)

Table 2. Regorafenib Annual Sales CAGR by Country/Region (2017, 2022 & 2028) & ($ millions)

Table 3. Major Players of Bottled Packaging

Table 4. Major Players of Film Coated Packaging

Table 5. Global Regorafenib Sales by Type (2017-2022) & (K Pcs)

Table 6. Global Regorafenib Sales Market Share by Type (2017-2022)

Table 7. Global Regorafenib Revenue by Type (2017-2022) & ($ million)

Table 8. Global Regorafenib Revenue Market Share by Type (2017-2022)

Table 9. Global Regorafenib Sale Price by Type (2017-2022) & (USD/Pcs)

Table 10. Global Regorafenib Sales by Application (2017-2022) & (K Pcs)

Table 11. Global Regorafenib Sales Market Share by Application (2017-2022)

Table 12. Global Regorafenib Revenue by Application (2017-2022)

Table 13. Global Regorafenib Revenue Market Share by Application (2017-2022)

Table 14. Global Regorafenib Sale Price by Application (2017-2022) & (USD/Pcs)

Table 15. Global Regorafenib Sales by Company (2020-2022) & (K Pcs)

Table 16. Global Regorafenib Sales Market Share by Company (2020-2022)

Table 17. Global Regorafenib Revenue by Company (2020-2022) ($ Millions)

Table 18. Global Regorafenib Revenue Market Share by Company (2020-2022)

Table 19. Global Regorafenib Sale Price by Company (2020-2022) & (USD/Pcs)

Table 20. Key Manufacturers Regorafenib Producing Area Distribution and Sales Area

Table 21. Players Regorafenib Products Offered

Table 22. Regorafenib Concentration Ratio (CR3, CR5 and CR10) & (2020-2022)

Table 23. New Products and Potential Entrants

Table 24. Mergers & Acquisitions, Expansion

Table 25. Global Regorafenib Sales by Geographic Region (2017-2022) & (K Pcs)

Table 26. Global Regorafenib Sales Market Share Geographic Region (2017-2022)

Table 27. Global Regorafenib Revenue by Geographic Region (2017-2022) & ($ millions)

Table 28. Global Regorafenib Revenue Market Share by Geographic Region (2017-2022)

Table 29. Global Regorafenib Sales by Country/Region (2017-2022) & (K Pcs)

Table 30. Global Regorafenib Sales Market Share by Country/Region (2017-2022)

Table 31. Global Regorafenib Revenue by Country/Region (2017-2022) & ($ millions)

Table 32. Global Regorafenib Revenue Market Share by Country/Region (2017-2022)

Table 33. Americas Regorafenib Sales by Country (2017-2022) & (K Pcs)

Table 34. Americas Regorafenib Sales Market Share by Country (2017-2022)

Table 35. Americas Regorafenib Revenue by Country (2017-2022) & ($ Millions)

Table 36. Americas Regorafenib Revenue Market Share by Country (2017-2022)

Table 37. Americas Regorafenib Sales by Type (2017-2022) & (K Pcs)

Table 38. Americas Regorafenib Sales Market Share by Type (2017-2022)

Table 39. Americas Regorafenib Sales by Application (2017-2022) & (K Pcs)

Table 40. Americas Regorafenib Sales Market Share by Application (2017-2022)

Table 41. APAC Regorafenib Sales by Region (2017-2022) & (K Pcs)

Table 42. APAC Regorafenib Sales Market Share by Region (2017-2022)

Table 43. APAC Regorafenib Revenue by Region (2017-2022) & ($ Millions)

Table 44. APAC Regorafenib Revenue Market Share by Region (2017-2022)

Table 45. APAC Regorafenib Sales by Type (2017-2022) & (K Pcs)

Table 46. APAC Regorafenib Sales Market Share by Type (2017-2022)

Table 47. APAC Regorafenib Sales by Application (2017-2022) & (K Pcs)

Table 48. APAC Regorafenib Sales Market Share by Application (2017-2022)

Table 49. Europe Regorafenib Sales by Country (2017-2022) & (K Pcs)

Table 50. Europe Regorafenib Sales Market Share by Country (2017-2022)

Table 51. Europe Regorafenib Revenue by Country (2017-2022) & ($ Millions)

Table 52. Europe Regorafenib Revenue Market Share by Country (2017-2022)

Table 53. Europe Regorafenib Sales by Type (2017-2022) & (K Pcs)

Table 54. Europe Regorafenib Sales Market Share by Type (2017-2022)

Table 55. Europe Regorafenib Sales by Application (2017-2022) & (K Pcs)

Table 56. Europe Regorafenib Sales Market Share by Application (2017-2022)

Table 57. Middle East & Africa Regorafenib Sales by Country (2017-2022) & (K Pcs)

Table 58. Middle East & Africa Regorafenib Sales Market Share by Country (2017-2022)

Table 59. Middle East & Africa Regorafenib Revenue by Country (2017-2022) & ($ Millions)

Table 60. Middle East & Africa Regorafenib Revenue Market Share by Country (2017-2022)

Table 61. Middle East & Africa Regorafenib Sales by Type (2017-2022) & (K Pcs)

Table 62. Middle East & Africa Regorafenib Sales Market Share by Type (2017-2022)

Table 63. Middle East & Africa Regorafenib Sales by Application (2017-2022) & (K Pcs)

Table 64. Middle East & Africa Regorafenib Sales Market Share by Application (2017-2022)

Table 65. Key Market Drivers & Growth Opportunities of Regorafenib

Table 66. Key Market Challenges & Risks of Regorafenib

Table 67. Key Industry Trends of Regorafenib

Table 68. Regorafenib Raw Material

Table 69. Key Suppliers of Raw Materials

Table 70. Regorafenib Distributors List

Table 71. Regorafenib Customer List

Table 72. Global Regorafenib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 73. Global Regorafenib Sales Market Forecast by Region

Table 74. Global Regorafenib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 75. Global Regorafenib Revenue Market Share Forecast by Region (2023-2028)

Table 76. Americas Regorafenib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 77. Americas Regorafenib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 78. APAC Regorafenib Sales Forecast by Region (2023-2028) & (K Pcs)

Table 79. APAC Regorafenib Revenue Forecast by Region (2023-2028) & ($ millions)

Table 80. Europe Regorafenib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 81. Europe Regorafenib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 82. Middle East & Africa Regorafenib Sales Forecast by Country (2023-2028) & (K Pcs)

Table 83. Middle East & Africa Regorafenib Revenue Forecast by Country (2023-2028) & ($ millions)

Table 84. Global Regorafenib Sales Forecast by Type (2023-2028) & (K Pcs)

Table 85. Global Regorafenib Sales Market Share Forecast by Type (2023-2028)

Table 86. Global Regorafenib Revenue Forecast by Type (2023-2028) & ($ Millions)

Table 87. Global Regorafenib Revenue Market Share Forecast by Type (2023-2028)

Table 88. Global Regorafenib Sales Forecast by Application (2023-2028) & (K Pcs)

Table 89. Global Regorafenib Sales Market Share Forecast by Application (2023-2028)

Table 90. Global Regorafenib Revenue Forecast by Application (2023-2028) & ($ Millions)

Table 91. Global Regorafenib Revenue Market Share Forecast by Application (2023-2028)

Table 92. Bayer Pharmaceuticals Basic Information, Regorafenib Manufacturing Base, Sales Area and Its Competitors

Table 93. Bayer Pharmaceuticals Regorafenib Product Offered

Table 94. Bayer Pharmaceuticals Regorafenib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 95. Bayer Pharmaceuticals Main Business

Table 96. Bayer Pharmaceuticals Latest Developments

Table 97. Beacon Pharmaceuticals Basic Information, Regorafenib Manufacturing Base, Sales Area and Its Competitors

Table 98. Beacon Pharmaceuticals Regorafenib Product Offered

Table 99. Beacon Pharmaceuticals Regorafenib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 100. Beacon Pharmaceuticals Main Business

Table 101. Beacon Pharmaceuticals Latest Developments

Table 102. Drug International Basic Information, Regorafenib Manufacturing Base, Sales Area and Its Competitors

Table 103. Drug International Regorafenib Product Offered

Table 104. Drug International Regorafenib Sales (K Pcs), Revenue ($ Million), Price (USD/Pcs) and Gross Margin (2020-2022)

Table 105. Drug International Main Business

Table 106. Drug International Latest Developments

List of Figures

Figure 1. Picture of Regorafenib

Figure 2. Regorafenib Report Years Considered

Figure 3. Research Objectives

Figure 4. Research Methodology

Figure 5. Research Process and Data Source

Figure 6. Global Regorafenib Sales Growth Rate 2017-2028 (K Pcs)

Figure 7. Global Regorafenib Revenue Growth Rate 2017-2028 ($ Millions)

Figure 8. Regorafenib Sales by Region (2021 & 2028) & ($ millions)

Figure 9. Product Picture of Bottled Packaging

Figure 10. Product Picture of Film Coated Packaging

Figure 11. Global Regorafenib Sales Market Share by Type in 2021

Figure 12. Global Regorafenib Revenue Market Share by Type (2017-2022)

Figure 13. Regorafenib Consumed in Metastatic Colorectal Cancer

Figure 14. Global Regorafenib Market: Metastatic Colorectal Cancer (2017-2022) & (K Pcs)

Figure 15. Regorafenib Consumed in Advanced Gastrointestinal Stromal Tumours

Figure 16. Global Regorafenib Market: Advanced Gastrointestinal Stromal Tumours (2017-2022) & (K Pcs)

Figure 17. Regorafenib Consumed in Advanced Hepatocellular Carcinoma

Figure 18. Global Regorafenib Market: Advanced Hepatocellular Carcinoma (2017-2022) & (K Pcs)

Figure 19. Regorafenib Consumed in Other

Figure 20. Global Regorafenib Market: Other (2017-2022) & (K Pcs)

Figure 21. Global Regorafenib Sales Market Share by Application (2017-2022)

Figure 22. Global Regorafenib Revenue Market Share by Application in 2021

Figure 23. Regorafenib Revenue Market by Company in 2021 ($ Million)

Figure 24. Global Regorafenib Revenue Market Share by Company in 2021

Figure 25. Global Regorafenib Sales Market Share by Geographic Region (2017-2022)

Figure 26. Global Regorafenib Revenue Market Share by Geographic Region in 2021

Figure 27. Global Regorafenib Sales Market Share by Region (2017-2022)

Figure 28. Global Regorafenib Revenue Market Share by Country/Region in 2021

Figure 29. Americas Regorafenib Sales 2017-2022 (K Pcs)

Figure 30. Americas Regorafenib Revenue 2017-2022 ($ Millions)

Figure 31. APAC Regorafenib Sales 2017-2022 (K Pcs)

Figure 32. APAC Regorafenib Revenue 2017-2022 ($ Millions)

Figure 33. Europe Regorafenib Sales 2017-2022 (K Pcs)

Figure 34. Europe Regorafenib Revenue 2017-2022 ($ Millions)

Figure 35. Middle East & Africa Regorafenib Sales 2017-2022 (K Pcs)

Figure 36. Middle East & Africa Regorafenib Revenue 2017-2022 ($ Millions)

Figure 37. Americas Regorafenib Sales Market Share by Country in 2021

Figure 38. Americas Regorafenib Revenue Market Share by Country in 2021

Figure 39. United States Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 40. Canada Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 41. Mexico Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 42. Brazil Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 43. APAC Regorafenib Sales Market Share by Region in 2021

Figure 44. APAC Regorafenib Revenue Market Share by Regions in 2021

Figure 45. China Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 46. Japan Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 47. South Korea Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 48. Southeast Asia Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 49. India Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 50. Australia Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 51. Europe Regorafenib Sales Market Share by Country in 2021

Figure 52. Europe Regorafenib Revenue Market Share by Country in 2021

Figure 53. Germany Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 54. France Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 55. UK Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 56. Italy Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 57. Russia Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 58. Middle East & Africa Regorafenib Sales Market Share by Country in 2021

Figure 59. Middle East & Africa Regorafenib Revenue Market Share by Country in 2021

Figure 60. Egypt Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 61. South Africa Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 62. Israel Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 63. Turkey Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 64. GCC Country Regorafenib Revenue Growth 2017-2022 ($ Millions)

Figure 65. Manufacturing Cost Structure Analysis of Regorafenib in 2021

Figure 66. Manufacturing Process Analysis of Regorafenib

Figure 67. Industry Chain Structure of Regorafenib

Figure 68. Channels of Distribution

Figure 69. Distributors Profiles